189 related articles for article (PubMed ID: 21093894)
1. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Wang FQ; Smicun Y; Calluzzo N; Fishman DA
Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
[TBL] [Abstract][Full Text] [Related]
3. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
4. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
[TBL] [Abstract][Full Text] [Related]
5. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
6. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases.
Wang FQ; So J; Reierstad S; Fishman DA
Int J Cancer; 2006 Feb; 118(4):879-88. PubMed ID: 16152587
[TBL] [Abstract][Full Text] [Related]
8. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Wang FQ; So J; Reierstad S; Fishman DA
Int J Cancer; 2005 Mar; 114(1):19-31. PubMed ID: 15523695
[TBL] [Abstract][Full Text] [Related]
9. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J; Navari J; Wang FQ; Fishman DA
Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
[TBL] [Abstract][Full Text] [Related]
11. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Devine KM; Smicun Y; Hope JM; Fishman DA
Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
13. S1P regulation of ovarian carcinoma invasiveness.
Smicun Y; Reierstad S; Wang FQ; Lee C; Fishman DA
Gynecol Oncol; 2006 Dec; 103(3):952-9. PubMed ID: 16956652
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.
Xu Y; Hu J; Zhang C; Liu Y
Mol Med Rep; 2017 Dec; 16(6):8530-8536. PubMed ID: 28990044
[TBL] [Abstract][Full Text] [Related]
15. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
